The Effectiveness of Chuna Maintenance Therapy for Chronic Bothersome Neck Pain
NCT ID: NCT06591221
Last Updated: 2025-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
250 participants
INTERVENTIONAL
2024-07-07
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Effectiveness and Cost-effectiveness of Chuna Manual Therapy for Chronic Neck Pain
NCT03294785
Effects of Manual Therapy Combined With Therapeutic Exercise on Brain Biomarkers in Neck Pain
NCT05568394
Chuna Manual Therapy for Cervicogenic Dizziness
NCT03291912
The Efficacy and Safety of Non-resistance Manual Therapy in Inpatients With Acute Neck Pain Caused by Traffic Accidents: a Randomised Controlled Trial
NCT04660175
Qigong and Exercise for Neck Pain in Adults (QENA)
NCT00615732
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chuna maintenance therapy group
This group will receive chuna therapy determined by the clinician based on the subject's symptoms, degree of improvement, etc. (1 time/2 weeks, total 20 weeks)
Chuna Maintenance Therapy
it is conducted every two weeks for a total of 20 weeks for individuals. The technique follows the guidelines of the Society of Chuna Manual Medicine and is based on Chuna Medicine (2.5th edition), which is utilized as a textbook in Korean Medicine colleges.
The treatment is selectively administered based on the clinical judgment of the practitioner.
Lifestyle management & self-exercise group
This group will perform lifestyle management and daily self-exercise. The exercise education will be performed per 4 weeks for total 20 weeks.
Chuna Maintenance Therapy
it is conducted every two weeks for a total of 20 weeks for individuals. The technique follows the guidelines of the Society of Chuna Manual Medicine and is based on Chuna Medicine (2.5th edition), which is utilized as a textbook in Korean Medicine colleges.
The treatment is selectively administered based on the clinical judgment of the practitioner.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chuna Maintenance Therapy
it is conducted every two weeks for a total of 20 weeks for individuals. The technique follows the guidelines of the Society of Chuna Manual Medicine and is based on Chuna Medicine (2.5th edition), which is utilized as a textbook in Korean Medicine colleges.
The treatment is selectively administered based on the clinical judgment of the practitioner.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Neck pain with pain duration of 12 months or longer
3. NRS of neck pain over the past month is 2 or more but less than 4
4. Patients who have agreed to trial participation and provided written informed consent
Exclusion Criteria
2. Patients with progressive neurologic deficit or severe neurologic symptoms such as spinal cord injury
3. Patients whose pain is due to soft tissue disease not the spine (e.g. tumors, fibromyalgia, rheumatoid arthritis, gout)
4. Patients with other chronic disease(s) which may interfere with treatment effect, safety, or interpretation of outcome (e.g. stroke and myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy)
5. Patients currently taking steroids, immunosuppressants, medicine for mental illness or other medication(s) that may interfere with study results
6. Pregnant patients or patients with plans of pregnancy or lactating patients
7. Patients within 3 months after cervical surgery
8. Patients with experience of participating in another clinical study within 1 month or plan to participate in another clinical study during the study participation and follow-up period within 6 months from the participation date
9. Patients having difficult to completing the written informed consent
10. Patients who are deemed unsuitable by the researchers
19 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jaseng Medical Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bucheon Jaseng Hospital of Korean Medicine
Bucheon-si, , South Korea
Daejeon Jaseng Hospital of Korean Medicine
Daejeon, , South Korea
Haeundae Jaseng Hospital of Korean Medicine
Haeundae, , South Korea
College of Korean Medicine, Kyung Hee University
Seoul, , South Korea
Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Kyung Hee University
Seoul, , South Korea
Jaseng Hospital of Korean Medicine
Seoul, , South Korea
School of Korean Medicine, Pusan National University
Yangsan, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Lee
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JS-CT-2024-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.